Cargando…

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome

BACKGROUND: Polycystic ovarian syndrome (PCOS), an endocrine and reproductive disorder consisting of hyperandrogenism, menstrual dysfunction and ovarian changes, affects 6–20% of reproductive aged women worldwide. While hyperandrogenemia is traditionally determined by evidence of elevated testostero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mody, Armaiti, Lodish, Maya Beth, Auchus, Richard Joseph, Huddleston, Heather Gibson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209052/ http://dx.doi.org/10.1210/jendso/bvaa046.551

Ejemplares similares

MON-LB040 Correlation Between Length of Hormone Therapy and Adverse Events in Transgender Veterans
por: Elliott, Karma-Jaya, et al.
Publicado: (2019)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

MON-210 Diagnostic Concordance of Hemoglobin A1c for Insulin Sensitivity Testing in Polycystic Ovarian Syndrome
por: Garvin, Sicily, et al.
Publicado: (2019)

OR27-06 11-Oxygenated C19 Steroids Are Alternative Markers of Androgen Excess in Children with Premature Adrenarche and Premature Pubarche
por: Wise-Oringer, Brittany K, et al.
Publicado: (2020)

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor
por: Tran, Kelvin, et al.
Publicado: (2020)

MON-004 Ovarian Steroid Cell Tumor, Not Otherwise Specified (NOS): A Case Report and Clinical Review
por: Lobaton, Miry, et al.
Publicado: (2020)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

MON-028 Chronic Resveratrol Exposure Improves Glucose Homeostasis and Cardiac Function in a Rat Model of Polycystic Ovarian Syndrome
por: Molina, Rogelio Enrique, et al.
Publicado: (2020)

SAT361 A Rare Case of Ovarian Steroid Cell Tumor in a Patient With Known Polycystic Ovarian Syndrome
por: Aluko, Oluwatomisin A, et al.
Publicado: (2023)

RF10 | PMON221 11-Oxygenated-Androgens in Females with Severe Insulin Resistance
por: Merke, Deborah, et al.
Publicado: (2022)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

MON-218 Inflammatory Role of Sex Steroids in Hidradenitis Suppurativa: An Androgenic Phenotype
por: Jaleel, Tarannum, et al.
Publicado: (2019)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

MON-207 Identification of Monogenic Causes of Polycystic Ovary Syndrome by High Throughput Sequencing
por: Crespo, Raiane, et al.
Publicado: (2019)

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
por: folawewo, kehinde Matilda, et al.
Publicado: (2020)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

SAT-040 Changes in Metabolic Parameters After Administration of Novel Oral Androgens with Progestational Activity for 28 Days
por: Yuen, Fiona, et al.
Publicado: (2020)

MON-268 A Rare Case of Primary Hypoaldosteronism in a Newborn
por: Mody, Armaiti, et al.
Publicado: (2019)

OR27-07 11-oxygenated C19 Steroids in Normal Weight, Overweight, and Hyperandrogenic Girls
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2020)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

MON-203 Local Activation of 11-Oxygenated Androgens by AKR1C3 Is the Predominant Source of Androgens in Human Female Adipose Tissue
por: Schiffer, Lina, et al.
Publicado: (2019)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

MON-211 The Negative Impact of Polycystic Ovary Syndrome in Bone Health: A Systematic Review and Meta-Analysis
por: Piovezan, Julia, et al.
Publicado: (2019)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

SUN-LB040 Associations of Testosterone and Sex Hormone Binding Globulin with the Risk of Cardiovascular Disease and Type 2 Diabetes in Men
por: Wittert, Gary, et al.
Publicado: (2019)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

MON-214 The Natural Course of Normal Weight Women with Polycystic Ovary Syndrome: An Insight into Metabolic Changes of Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2019)

MON-030 Intermediate Hyperglycemia and Type 2 Diabetes in Women with Polycystic Ovary Syndrome: Findings from Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2020)

MON-012 The Direct Effect of Kisspeptin on Human Ovarian Granulosa Cells to Regulate Steroidogenesis
por: Qin, Lixian, et al.
Publicado: (2020)

MON-041 Diagnostic Performance of Ovarian Morphology for Anovulatory Conditions in Lean and Overweight Women
por: Brink, Heidi Vanden, et al.
Publicado: (2020)

SAT-LB040 Measuring LH Pulsatility in Patients with Reproductive Disorders Using a Novel Robotic Aptamer-Enabled Electrochemical Reader (RAPTER)
por: Dhillo, Waljit, et al.
Publicado: (2019)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

MON-042 The Effect of Exercise Training on Reproductive and Cardiometabolic Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial
por: Benham, Jamie L, et al.
Publicado: (2020)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

MON-002 The Effect of GNRHR Autoantibody on Reproduction Function and Insulin Signaling Intermediates in a New Animal Model of Polycystic Ovary Syndrome
por: Li, Hongliang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ogqd66tqi90194uvs4584f8h8